Cellular and molecular mechanisms of inflammation and thrombosis

European Journal of Vascular and Endovascular Surgery

Volumn 17, Issue 5, 1999, Pages 373-389

  Tan, P ^a   Luscinskas, F W ^b   Homer Vanniasinkam, S ^c  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Cell adhesion molecules; Chemokines; Inflammation; Neutrophils; Thrombosis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHEMOKINE; GLYCOPROTEIN; INTEGRIN; SELECTIN;

CELL ADHESION; DIABETIC ANGIOPATHY; HEMOSTASIS; HUMAN; INFLAMMATION; LEUKOCYTE; MOLECULAR CLONING; MOLECULAR INTERACTION; PRIORITY JOURNAL; REPERFUSION INJURY; RESTENOSIS; REVIEW; SEPSIS; SEQUENCE ANALYSIS; THROMBOCYTE; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0033135772     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1998.0759     Document Type: Article

References (181)

1. Hunter J. Treatise on the blood inflammation and gunshot wounds. In: Palmer JF, ed. The Surgical Works of John Hunter, F.R.S. London: Longman, Rees, Orme, Brown, Green and Longman, 1835;1-580.
2. Gimbroke MA, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium. An integreator of pathophysiological stimuli in atherogenesis. Ann New York Acad Sci. 748:1995;122-132.
3. Pober JS, Cotran RS. Overview: the role of endothelial cells in inflammation. Transplantation. 50:1990;537-544.
4. Frangos JA, Eskin SG, McIntyre LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science. 227:1985;1477-1479.
5. Rubanyi GM, Romero JC, Vanhoutte PM. Flow induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
6. Nagel T, Resnick N, Atkinson WJ, Dewey CF, Gimbrone MA. Shear stress selectively up-regulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest. 94:1994;885-891.
7. Luscinskas FW, Gimbrone MA. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med. 47:1996;413-421.
8. Wellicome SM, Thornhill MH, Pitzalis C. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccharide. J Immunol. 144:1990;2558-2565.
9. McEver RP, Beckstead JH, Moore KL, Marshall-Colson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 84:1989;92-106.
10. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible endothelial- leukocyte adhesion molecule. Proc Natl Acad Sci USA. 84:1987;9238-9242.
11. Pober JS, Gimbrone MA, Lapierre LA. Overlapping patterns of activation by human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J Immunol. 137:1986;1893-1896.
12. 4stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA. 83:1986;2204-2208.
13. Gimbrone MA, Obin MS, Brock AF. Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions. Science. 246:1989;1601-1603.
14. Collins T. Biology of disease. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 68:1993;499-508.
15. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243:1989;1160-1165.
16. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb. 12:1992;135-145.
17. Carmeliet P, Collen D. Gene targetting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neo-intima formation and atherosclerosis. FASEB J. 9:1995;934-938.
18. Mackman N. Regulation of the tissue factor gene. FASEB J. 9:1995;883-889.
19. Martin DMA, Boys CWG, Ruf W. Tissue factor: molecular recognition and co-factor function. FASEB J. 9:1995;852-859.
20. Sawa H, Fujii S, Sobel BE. Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis. Arterioscler Thromb. 12:1992;1507-1515.
21. Metchnikof f, E. Lectures on the Comparative Pathology of Inflammation . New York: Dover Publications Inc (re-publication of original edition by Kegan, Paul, Trench Trubner and CoLondon, 1893), 1968.
22. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev. 114:1990;181-217.
23. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
24. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 88:1996;3259-3287.
25. Luscinskas FW, Cybulsky MI, Kiely JM. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol. 146:1991;1617-1625.
26. Lorant DE, Patel KD, McIntyre TM. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol. 115:1991;223-234.
27. 2-integrins. J Cell Biol. 125:1994;1417-1427.
28. Ley K, Gaehtgens P, Fennie C. Lectin-like cell adhesion molecule-1 mediates rolling in mesenteric venules in vivo. Blood. 77:1991;2553-2555.
29. 2integrins in vivo. Proc Natl Acad Sci USA. 88:1991;7538-7542.
30. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P-selectin-deficient mice. Cell. 74:1993;541-554.
31. Arbones MI, Ord DC, Ley K. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin (CD62L)-deficient mice. Immunity. 1:1994;247-260.
32. Labow MA, Norton CR, Rumberger JM. Characterization of E-selectin deficient mice demonstration of overlapping function of the endothelial selectins. Immunity. 1:1994;709-720.
33. Bullard DC, Qin L, Lorenzo L. P-selectin/ICAM-1 double mutant mice acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest. 95:1995;1782-1788.
34. Arnaout MA. Leukocyte adhesion molecule deficiency, its structural basis, pathophysiology and implications for moduÍlating the inflammatory response. Immunol Rev. 114:1990;147-180.
35. Price TH, Ochs HD, Gershoni-Baruch R, Harlan JM, Etzioni A. In vivo neutrophil and lymphocyte function studies in a patient with leukocyte adhesion deficiency type II. Blood. 84:1994;1635-1639.
36. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
37. Tedder TF, Luskinkas FW, Kansas GS. Regulation of leukocyte migration by L-selectin: mechanism, domains and ligands. Behring Inst Mitt. 92:1993;165-177.
38. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 245:1989;1238-1241.
39. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today. 14:1994;506-512.
40. Schleif fenbaum B, Spertini O, Tedder TF,. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol. 119:1992;229-238.
41. Allport JR, Ding H, Ager A. L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium. J Immunol. 158:1997;4368-4372.
42. Koch AE, Burrows JC, Haines GK. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest. 64:1991;313-320.
43. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC. ELAM-1 is an adhesion molecule for skin-homing T-cells. Nature. 349:1991;796-799.
44. Varki A. Selectin ligands. Proc Natl Acad USA. 91:1994;7390-7397.
45. Sako D, Chang XJ, Barone KM. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1993;1179-1186.
46. Moore KL, Patel KD, Bruehl RE. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 126:1995;661-671.
47. Guyer DA, Moore KL, Lynam EB. P-selectin glycoprotein ligand (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood. 88:1996;2415-2421.
48. Goetz DJ, Greif DM, Ding H. Isolated P-selectin glycoprotein ligand-1 dynamic adhesion to P- and E-selectin. J Cell Biol. 137:1997;509-519.
49. Patel KD, Moore KL, Nollert MU, McEver RP. Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J Clin Invest. 96:1996;1887-1896.
50. Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest. 98:1996;1081-1087.
51. Spertini O, Luscinskas FW, Kansas GS. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol. 147:1991;2565-2573.
52. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8:1994;929-938.
53. Anderson DC, Miller LJ, Schmalstieg FC, Rothlein R, Springer TA. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions structure-function assessment employing subunit-specific monoclonal antibodies. J Immunol. 137:1986;15-27.
54. Bainton DF, Miller LJ, Kishimoto TK, Springer TA. Leukocyte adhesion receptors are stored in peroxidase-negative granules of human neutrophils. J Exp Med. 166:1987;1641-1653.
55. Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. 120:1993;545-566.
56. Fearon DT, Collins LA. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol. 130:1983;370-375.
57. Arnaout MA. Structure and function of leukocyte adhesion molecules CD11/CD18. Blood. 75:1990;1037-1050.
58. 2+binding epitope on leukocyte integrin a subunits. EMBO J. 8:1989;3759-3765.
59. Dustin ML, Springer TA. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol. 107:1988;321-331.
60. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature. 339:1989;61-64.
61. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function associated molecule-1 on resting lymphocytes. J Exp Med. 175:1992;185-190.
62. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD1b/CD18) to the third Ig-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 65:1991;961-971.
63. Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type 3 complement receptor. J Exp Med. 156:1982;1000-1009.
64. Myones BL, Dalzell JG, Hogg N, Ross GD. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest. 82:1988;640-651.
65. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 137:1986;1270-1274.
66. Marlin SD, Staunton DE, Springer TA. A soluble form of intercellular adhesion molecule-1 (ICAM-1) inhibits rhinovirus infection. Nature. 344:1990;70-72.
67. Berendt AR, Simmons DL, Tansy J, Newbold CI. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 341:1989;57-59.
68. Meyer, DM, Dustin, ML, Carron, CP, Characterization of intercellular adhesion molecule-1 ectodomain (slCAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol, 155, 3578, 3584.
69. de Fougerolles AR, Stacker SA, Schwartting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med. 174:1991;253-267.
70. Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18 independent mechanism. J Exp Med. 171:1990;1369-1374.
71. Osborn L, Hession C, Tizard R. Direct expression cloning of vascular adhesion molecule-1, a cytokine induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
72. Marlor CW, Webb DL, Bombara MP, Greve JM, Blue ML. Expression of vascular cell adhesion molecule-1 in fibroblast-like synoviocytes after stimulation with tumor necrosis factor. Am J Pathol. 140:1992;1055-1060.
73. Bochner BS, Luscinskas FW, Gimbrone MA. Adhesion of human basophils, eosinophils and neutrophils to interleukin-1 activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 173:1991;1553-1556.
74. Kume N, Cybulsky MI, Gimbrone MA. LysophosÍphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.
75. Schleimer RP, Stebinsky SA, Kaiser J. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol. 148:1992;1086-1092.
76. Elices MJ, Osborn L, Tanaka Y. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a binding site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
77. Berlin C, Bargatze RF, Campbell JJ. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:1995;413-422.
78. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (EndocCAM/CD31). A novel vascular cell-cell adhesion molecule. J Cell Biol. 114:1991;1059-1068.
79. Romer LH, McLean NV, Yan HC. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol. 154:1995;6582-6592.
80. Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol. 157:1996;1233-1241.
81. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 178:1993;449-460.
82. Liao F, Huynh HK, Eiroa A. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med. 182:1996;1337-1343.
83. 3integrin involved in adhesion of leukocytes to endothelium. J Cell Biol. 130:1995;451-460.
84. Palabrica T, Lobb R, Furie BC. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:1992;848-851.
85. Kieffer N, Phillips DR. Platelet membrane glycoproteins: Functions in cellular interactions. Annu Rev Cell Biol. 6:1990;329-357.
86. Coller BS. Platelets and thrombolytic therapy. N Engl J Med. 322:1990;33-42.
87. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIB-IIIa complex. Blood. 71:1988;831-843.
88. Plow EF, Ginsberg MH. Cellular adhesion gpIIb-IIIa as a prototype adhesion receptor. Prog Hemost Thromb. 9:1989;117-156.
89. Movat, HZ. Chemotaxis. In: Movat HZ, ed. The Inflammatory Reaction. Amsterdam: Elsevier, 1985, 203, 257.
90. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Ann Rev Immunol. 9:1991;617-648.
91. Ben-Baruch A, Michiel DF, Oppenheim JJ. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem. 270:1995;11703-11706.
92. Gerard, C, Gerard, NP. Molecular biology of human neutrophil chemotactic receptors. In: Hellewell PG, Williams TJ, eds. Immunopharmacology of Neutrophils. London: Academic Press, 1994, 115, 131.
93. Kelvin DJ, Michiel DF, Johnston JA. Chemokines and serpentines: the molecular biology of chemokine receptors. J Leuk Biol. 54:1993;604-612.
94. Devreotes PN, Zigmond SH. Chemotaxis in eukaryotic cells: a focus on leukocytes and Diotyostelium. Ann Rev Cel Biol. 4:1988;649-686.
95. Goetzl EJ, Picket WC. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med. 153:1981;482-487.
96. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications. Lab Invest. 69:1993;639-650.
97. Pinckard RN, Jackson EM, Hoppens C. Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 122:1984;325-332.
98. Prescott SM, Zimmerman GA, McIntyre TM. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Nat Acad Sci USA. 81:1984;3534-3538.
99. Evangelou AM. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukotrienes and Essential Fatty Acids. 50:1994;1-28.
100. Ward PA, Newman LJ. A neutrophil chemotactic factor from human C′5. J Immunol. 102:1969;93-99.
101. Schif fman E, Corcoran B, Wahl SM. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc Nat Acad Sci USA. 72:1975;1059-1062.
102. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol. 146:1995;1287-1301.
103. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor. J Immunol. 144:1990;2205-2210.
104. Zachariae COC, Anderson AO, Thompson HL. Properties of monocyte chemotactic and activating factor purified from a human fibrosarcoma cell line. J Exp Med. 171:1990;2177-2182.
105. Bussolino F, Sironi M, Bocchietto E, Mantovani A. Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with IL-8. J Biol Chem. 267:1992;14598-14603.
106. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 148:1992;2423-2428.
107. Modi WS, Dean M, Seuanez HN. Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor gene family. Hum Genet. 84:1990;185-187.
108. Taub DD, Lloyd AR, Conlon K. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 177:1993;1809-1814.
109. Deuel TF, Senior RM, Chand D. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA. 78:1981;4584-4587.
110. Leonard EJ, Skeel A, Yoshimura T. Leukocyte specificity and binding of human neutrophil attractant/activating protein 1. J Immunol. 144:1990;1323-1330.
111. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 169:1989;1485-1490.
112. Schall TJ, Bacon K, Toy KI, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 34:1990;769-771.
113. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med. 115:1962;453-466.
114. Cutler JE. A simple in vitro method for the study of chemotaxis. Proc Soc Exp Biol Med. 147:1974;471-474.
115. Keller HU, Wilkinson PC, Abercrombie M. A proposal for the definition of terms related to locomotion of leukocytes and other cells. Clin Exp Immunol. 27:1977;377-380.
116. Peiper SC, Wang ZX, Neote K. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 181:1995;1311-1317.
117. Horuk R. The interleukin-8-receptor family from chemokines to malaria. Immunol Today. 15:1994;169-174.
118. Broaddus VC, Hebert CA, Vitangcol RV. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis. 146:1992;825-830.
119. Koch AE, Kunkel SL, Burrows JC. Synovial tissue macrophages as a source of the chemotactic cytokine IL-8. J Immunol. 147:1991;2187-2195.
120. Strieter RM, Koch AE, Antony VB. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med. 123:1994;183-197.
121. Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA. Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology. 84:1995;227-232.
122. Tan, P, Homer-Vanniasinkam, S, Gimbrone, MA, Luscinskas, FW. Role of chemoattractants in neutrophil recruitment to sites of information. In: Paul LC, Issekutz TB, eds. Adhesion Molecules in Health and Disease. New York: Marcel Dekker, 1997, 257, 287.
123. Ley K, Gaehtgens P. Endothelial, not hemodynamic differences are responsible for preferential leucocyte rolling in venules. Circ Res. 69:1991;1034-1041.
124. Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest. 87:1991;1798-1804.
125. Lawrence MB, Smith CW, Eskin SG, McIntyre LV. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood. 75:1990;227-237.
126. Movat, HZ. The vascular phenomena of acute inflammation. In: Movat HZ, ed. The Inflammatory Reaction. Amsterdam: Elsevier, 1985, 43, 75.
127. Schmid-Schonbein GW, Usami S, Skalak R, Chien S. The interaction of leukocytes and erythrocytes in capillary and post-capillary vessels. Microvasc Res. 19:1980;45-70.
128. Nobis U, Pries AR, Cokelet GR, Gaehtgens P. Radial distribution of white cells during blood flow in small tubes. Microvasc Res. 29:1985;295-304.
129. Tozeren A, Ley K. How do selectins mediate leukocyte rolling in venules? Biophys J. 63:1992;700-709.
130. -(naive) T cells roll efficiently on E- and P-selectin and VCAM-1 under flow. J Immunol. 158:1997;3640-3650.
131. Atherton A, Born GV. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessels. J Physiol. 222:1972;447-474.
132. Atherton A, Born GV. Relationship between the velocity of rolling granulocytes and that of the blood flow in venules. J Physiol. 233:1973;157-165.
133. Finger EB, Puri KD, Alon R. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature. 379:1996;266-269.
134. Granger DN, Kubes P. The microcirculation and inflammation modulation of leukocyte-endothelial cell adhesion. J Leuk Biol. 55:1994;662-675.
135. Bargatze RF, Kurk S, Butcher EC, Jutila MA. Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J Exp Med. 180:1994;1785-1792.
136. Alon R, Fuhlbrigge RC, Finger EB, Springer TA. Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol. 135:1996;849-865.
137. 2integrin (Mac-1) and L-selectin (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM. J Histochem Cytochem. 41:1993;327-333.
138. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 254:1991;99-102.
139. 1integrin-mediated adhesion. J Exp Med. 176:1992;245-253.
140. Goodman RB, Wood RG, Martin TR, Hanson-Painton O, Kinasewitz GT. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol. 148:1992;457-465.
141. Rolfe MW, Kunkel SL, Standiford TJ. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol. 5:1991;493-501.
142. Topley N, Brown Z, Jorres A. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1-beta and tumor necrosis factor-alpha. Am J Pathol. 142:1993;1876-1886.
143. Jaf fe EA, Grulich J, Weksler BB, Hampel G, Watanabe K. Correlation between thrombin-induced prostacyclin production and inositol triphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem. 262:1987;8557-8565.
144. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ. Neutrophil chemoattractants generated in two-phases during reperfusion of ischemic myocardium in the rabbit. J Clin Invest. 95:1995;2720-2728.
145. McDonald PP, Pouliot M, Borgeat P, McColl SR. Induction of chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. J Immunol. 151:1993;6399-6409.
146. 2+influx, synergism with platelet-activating factor and significance for chemotaxis. J Biol Chem. 269:1994;4746-4753.
147. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
148. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolaemia in the non-human primates. Changes that lead to fatty streak formation. Arteriosclerosis. 4:1984;323-340.
149. Li H, Cybulsky MI, Gimbrone MA, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulated mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 13:1993;197-204.
150. Stemme S, Holm J, Hansson GK. T-lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 12:1992;206-211.
151. Davies MJ, Gordon JL, Gearing AJ, Piggott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerotic plaques. J Pathol. 171:1993;223-229.
152. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerosis plaques. Co-expression with intercellular adhesion molecule-1. Am J Pathol. 144:1994;952-961.
153. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-a secretion. J Clin Invest. 95:1995;2297-2303.
154. Cushing SD, Berliner JA, Valente AJ. Minimally modified low density lipoprotein induces monocyte chemoattractant protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
155. Ku G, Thomas CE, Akeson AL, Jackson RL. Induction of interleukin-1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem. 267:1992;14183-14188.
156. Thomas CE, Jackson RL, Ohleiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1β release from human blood mononuclear cells. J Lipid Res. 35:1994;417-427.
157. Libby P, Warner SJ, Friedman GB. Interleukin-1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 81:1988;487-498.
158. Clinton SK, Underwood R, Hayes L. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 140:1992;301-316.
159. Brownlee M, Cerami A, Vlassara H. Advanced glycation end products in tissues and the biochemical basis of diabetic complications. N Engl J Med. 318:1988;1315-1321.
160. Kirstein M, Brett J, Radoff S. Advanced protein glycosylation induced transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA. 87:1990;9010-9014.
161. Read MA, Neish AS, Luscinskas FW. The proteasome pathway is required for cytokine-induced endothelial leukocyte adhesion molecule expression. Immunity. 2:1995;493-506.
162. Pierce JW, Schoenleber R, Jesmok G. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 272:1997;21096-21103.
163. Vedder NB, Winn RK, Rice CL. A monoclonal antibody to the adherence promoting leukocyte glycoprotein CD18 reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest. 81:1988;939-944.
164. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischaemia/reperfusion. J Clin Invest. 95:1995;2510-2519.
165. Sharar SR, Winn RK, Murry CE, Harlan JM, Rice CL. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high dose S. aureus injection in rabbits. Surgery. 116:1991;213-219.
166. Mileski WJ, Raymond JF, Winn RK, Harlan JM, Rice CL. Transient inhibition of neutrophil adherence with the anti-CD18 monoclonal antibody 60.3 does not increase mortality rates in abdominal sepsis. Surgery. 109:1991;497-501.
167. Walker PM. Ischemia/reperfusion injury in skeletal muscle. Ann Vasc Surg. 5:1991;399-402.
168. Williams, FM. Role of neutrophils in reperfusion injury. In: Hellewell PJ, Williams T, eds. Immunopharmacology of Neutrophils. London: Academic Press, 1994, 245, 257.
169. Welbourn CR, Goldman G, Paterson IS. Pathophysiology of ischemia reperfusion injury: central role of the neutrophil. Br J Surg. 78:1991;651-655.
170. Walden DL, McCutchan HJ, Enquist EJ. Neutrophils accumulate and contribute to skeletal muscle dysfunction after ischemia-reperfusion. Am J Physiol. 259:1990;H1809-H1812.
171. Sisley AC, Desai T, Harig JM, Gewertz BL. Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res. 57:1994;192-196.
172. Crinnion JN, Homer-Vanniasinkam S, Parkin SM, Gough MJ. Role of neutrophil-endothelial adhesion in skeletal muscle reperfusion injury. Br J Surg. 83:1996;251-254.
173. Mehta J. Platelets and prostaglandins in coronary artery disease: rationale for use of platelet-suppressive drugs. JAMA. 249:1983;2818-2823.
174. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 348:1996;1329-1339.
175. Coukell AJ, Markham A. Clopidogrel. Drugs. 54:1997;745-750.
176. Topol EJ, Calif f RM, Weisman HF. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 343:1994;881-886.
177. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
178. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularisation. N Engl J Med. 336:1997;1689-1696.
179. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 77:1988;142-150.
180. Jang I, Gold HK, Ziskind AA. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation. 79:1989;920-928.
181. Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest. 77:1986;2001-2009.